Cargando…

Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses

Clinical trials on the use of COVID-19 convalescent plasma remain inconclusive. While data on safety is increasingly available, evidence for efficacy is still sparse. Subgroup analyses hint to a dose-response relationship between convalescent plasma neutralizing antibody levels and mortality. In par...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schlickeiser, Stephan, Schwarz, Tatjana, Steiner, Sophie, Wittke, Kirsten, Al Besher, Nabeel, Meyer, Oliver, Kalus, Ulrich, Pruß, Axel, Kurth, Florian, Zoller, Thomas, Witzenrath, Martin, Sander, Leif Erik, Müller, Marcel A., Scheibenbogen, Carmen, Volk, Hans-Dieter, Drosten, Christian, Corman, Victor M., Hanitsch, Leif G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878374/ https://www.ncbi.nlm.nih.gov/pubmed/33584731 http://dx.doi.org/10.3389/fimmu.2020.628971

Ejemplares similares

SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity
por: Steiner, Sophie, et al.
Publicado: (2022)

Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology
por: Steiner, Sophie, et al.
Publicado: (2021)

Impaired B Cell Recall Memory and Reduced Antibody Avidity but Robust T Cell Response in CVID Patients After COVID-19 Vaccination
por: Steiner, Sophie, et al.
Publicado: (2023)

HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients
por: Steiner, Sophie, et al.
Publicado: (2020)

Author Correction: A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity
por: Kedor, Claudia, et al.
Publicado: (2022)

A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity
por: Kedor, Claudia, et al.
Publicado: (2022)

Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study
por: Mühlemann, Barbara, et al.
Publicado: (2021)

Polymorphism in COMT is associated with IgG(3) subclass level and susceptibility to infection in patients with chronic fatigue syndrome
por: Löbel, Madlen, et al.
Publicado: (2015)

Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray
por: Loebel, Madlen, et al.
Publicado: (2017)

SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients
por: Schwarz, Tatjana, et al.
Publicado: (2021)

Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Szklarski, Marvin, et al.
Publicado: (2021)

Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)
por: Haffke, Milan, et al.
Publicado: (2022)

Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers
por: Tober-Lau, Pinkus, et al.
Publicado: (2021)

Prophylaktisches und therapeutisches Management erhöhter Infektionsanfälligkeit bei Immundefekten
por: Hanitsch, Leif G.
Publicado: (2022)

CD4+ T Cell Dependent B Cell Recovery and Function After Autologous Hematopoietic Stem Cell Transplantation
por: Heck, Clarissa, et al.
Publicado: (2021)

CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity
por: Doehn, Jan-Moritz, et al.
Publicado: (2021)

Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome
por: Loebel, Madlen, et al.
Publicado: (2014)

Late-Onset Antibody Deficiency Due to Monoallelic Alterations in NFKB1
por: Schröder, Claudia, et al.
Publicado: (2019)

Pyoderma outbreak among kindergarten families: Association with a Panton-Valentine leukocidin (PVL)-producing S. aureus strain
por: Leistner, Rasmus, et al.
Publicado: (2017)

Editorial: SARS-COV-2 infections within inborn errors of immunity populations
por: Hanitsch, Leif Gunnar, et al.
Publicado: (2023)

A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model
por: Kreye, Jakob, et al.
Publicado: (2020)

Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February–March 2021
por: Tober-Lau, Pinkus, et al.
Publicado: (2021)

A Pathogenic Missense Variant in NFKB1 Causes Common Variable Immunodeficiency Due to Detrimental Protein Damage
por: Fliegauf, Manfred, et al.
Publicado: (2021)

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
por: Gruell, Henning, et al.
Publicado: (2022)

Adding a piece to the puzzle of Latin American blood donors and the potential risk of Trypanosoma cruzi transmission in Germany
por: Ullrich, Julian, et al.
Publicado: (2022)

Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections
por: Tober-Lau, Pinkus, et al.
Publicado: (2022)

Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19
por: Thibeault, Charlotte, et al.
Publicado: (2023)

Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent Hemodialysis
por: Lingscheid, Tilman, et al.
Publicado: (2022)

Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma
por: von Rhein, Christine, et al.
Publicado: (2021)

Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study
por: Thibeault, Charlotte, et al.
Publicado: (2021)

Outpatient decolonization after recurrent skin infection with Panton-Valentine leukocidin (PVL)-producing S. aureus—The importance of treatment repetition
por: Hanitsch, Leif G., et al.
Publicado: (2020)

Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS
por: Jäkel, Bianka, et al.
Publicado: (2021)

Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies—An Interim Report
por: Stein, Elisa, et al.
Publicado: (2023)

Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study
por: Lingscheid, Tilman, et al.
Publicado: (2022)

Post-treatment haemolysis is common following oral artemisinin combination therapy of uncomplicated malaria in travellers
por: Kurth, Florian, et al.
Publicado: (2023)

Coronaviren als Ursache respiratorischer Infektionen
por: Corman, V. M., et al.
Publicado: (2019)

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
por: Hillus, David, et al.
Publicado: (2021)

Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis
por: Schrezenmeier, Eva, et al.
Publicado: (2021)

Rezidivierende Larynxpapillomatose
por: Coordes, Annekatrin, et al.
Publicado: (2022)

The Value of a Rapid Test of Human Regulatory T Cell Function Needs to be Revised
por: Wendering, Desiree J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nl3crhm97agrqjvjkubr23lv97